| Literature DB >> 35270813 |
Nozomu Oya1, Nobutaka Ayani1,2, Akiko Kuwahara1, Riki Kitaoka1, Chie Omichi1,3, Mio Sakuma4, Takeshi Morimoto4, Jin Narumoto1.
Abstract
Medication use can increase the risk of falls and injuries in nursing homes, creating a significant risk for residents. We performed a retrospective cohort study over one year to identify the incidence of drug-related falls with and without injury among four Japanese nursing homes with 280 beds. We evaluated the relationship between potential risk factors for falls and fall-related injuries while considering well-known risks such as ADLs and chronic comorbidities. By collaboratively reviewing care records, we enrolled 459 residents (mean age, 87) and identified 645 falls, including 146 injurious falls and 16 severe injurious falls requiring inpatient care, incidence: 19.5, 4.4, 0.5 per 100 resident-months, respectively. Medication influenced around three-quarters of all falls, >80% of which were psychotropic drugs. Regularly taking ≥5 medications was a risk factor for the initial falls (HR 1.33: CI 1.00-1.77, p = 0.0048) and injuries after falls (OR 2.41: CI 1.30-4.50, p = 0.006). Our findings on the incidence of falls with and without injury were similar to those in Western countries, where the use of psychotropic medication influenced >50% of falls. Discontinuing unnecessary medication use while simultaneously assessing patient ADLs and comorbidities with physicians and pharmacists may help to avoid falls in nursing homes.Entities:
Keywords: adverse drug event; dementia; fall; nursing home; polypharmacy; psychotropic drugs
Mesh:
Substances:
Year: 2022 PMID: 35270813 PMCID: PMC8910089 DOI: 10.3390/ijerph19053123
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Outline of review process.
Characteristics of residents.
| Variables | ALL | Fallers † | Non-Fallers | Χ2 or | |
|---|---|---|---|---|---|
| Female, | 344 (75) | 157 (77) | 187 (73) | 0.79 | 0.4 |
| Age, mean (SD) (years) | 87.0 (6.9) | 87.3 (6.5) | 86.9 (7.2) | 0.50 | 0.7 |
| Length of stay, median (IQR) (days) | 113 (0–760) | 148 (0–776) | 104 (0–738) | −0.48 | 0.6 |
| No. of all drugs §, median (IQR) | 4 (2–6) | 5 (3–7) | 4 (2–6) | 2.37 | 0.02 |
| Polypharmacy §,¶, | 210 (46) | 105 (51) | 105 (41) | 4.84 | 0.03 |
| No. of psychotropic drugs §, median (IQR) | 0 (0–1) | 1 (0–2) | 0 (0–1) | 3.55 | <0.001 |
| Psychotropic drugs §,#, | 228 (49.6) | 115 (56) | 113 (44) | 6.61 | 0.01 |
| BZDRAs §,$, | 115 (25) | 68 (33) | 47 (18) | 13.4 | <0.001 |
| Antipsychotic drugs §, | 332 (72) | 59 (29) | 68 (27) | 0.29 | 0.6 |
| Antiepileptic drugs §, | 65 (14) | 38 (19) | 27 (11) | 6.73 | 0.01 |
| Antidepressant drugs §, | 29 (6.3) | 16 (7.8) | 13 (5.1) | 1.43 | 0.2 |
| Antihypertensive drugs §, | 206 (45) | 95 (47) | 111 (44) | 0.42 | 0.5 |
| Dementia, | 406 (88) | 181 (89) | 225 (88) | 0.03 | 0.9 |
| Charlson Comorbidity Index, median (IQR) | 1 (1–3) | 1 (1–3) | 2 (1–3) | −2.47 | 0.006 |
| Body mass index, median (IQR) | 19.7 (17.5–21.9) | 20.3 (18.0–22.3) | 19.0 (17.1–21.8) | 1.92 | 0.06 |
| Barthel Index), median (IQR) | 50 (25–80) | 65 (45–80) | 45 (10–75) | 5.83 | <0.001 |
| Barthel Index ≥ 60 (independent, mildly dependent), | 213 (46) | 114 (56) | 99 (39) | 13.3 | <0.001 |
SD, standard deviation; IQR, interquartile range; BZDRAs, benzodiazepine receptors agonists (benzodiazepines and non-benzodiazepines). † Residents who fell at least once during this study. § Presence of prescriptions at the beginning of this study including antipsychotics, antidepressants. ¶ The number of medications was five or more at the beginning of this study. # Including antipsychotics (atypical), antipsychotics (typical), antidepressants (SSRI, SNRI, NaSSA), antidepressants (other), sedatives (benzodiazepines and non-benzodiazepines), sedatives (other), anxiolytics, antiepileptics, anti-parkinsonian drugs and antidementia medicines. $ Including sedatives and anxiolytics as benzodiazepine receptors agonists.
Figure 2Severity of falls.
Factors influencing each fall.
| Factors (Multiple Selections Were Possible) | |
|---|---|
| No. of falls, | 645 |
| Medications (i.e., ADEs *1), | 480 (74) |
| Physical conditions *2, | 375 (58) |
| Psychiatric conditions, | 315 (49) |
| Operation errors of wheelchairs, | 25 (3.9) |
| Mistakes during caregiving, | 25 (3.9) |
| Slip of their feet, | 12 (1.9) |
| Trouble with clothes(trousers)/shoes, | 9 (1.4) |
| Obstacles at their feet, | 8 (1.2) |
| Operation errors of walking frames, | 7 (1.1) |
| Troubles with others *3, | 4 (0.6) |
| Unspecified, | 29 (4.5) |
*1 ADE; adverse drug event; *2 Including impaired walking patterns, impaired balance, reduced muscle strength, acute medical illness; *3 Excluding falls without other causes.
Hazard ratios of fall occurrence from Cox proportional hazard models.
| Risk Factor | Crude HR | 95% CI | Adjusted HR | 95% CI |
|---|---|---|---|---|
| No. of medication ¶ ≥ 5 | 1.37 | 1.04–1.80 | 1.33 | 1.00–1.77 |
| Female | 0.86 | 0.63–1.21 | 0.80 | 0.57–1.11 |
| Age ≥ 85 | 0.96 | 0.72–1.28 | 1.02 | 0.75–1.37 |
| Dementia | 0.97 | 0.64–1.53 | 1.03 | 0.65–1.63 |
| CCI ≥ 3 | 0.82 | 0.60–1.11 | 0.83 | 0.60–1.15 |
| BMI < 20 | 0.81 | 0.61–1.07 | 0.89 | 0.67–1.18 |
| Barthel Index ≥ 60 | 1.48 | 1.12–1.95 | 1.44 | 1.08–1.92 |
HR, hazard ratio; CI, confidence interval; CCI, Charlson comorbidity index; BMI, body mass index. ¶ The number of medications was five or more at the beginning of this study.
Characteristics between fallers with and without injuries.
| Variables | All Fallers | Fallers | Fallers | Χ2 or | |
|---|---|---|---|---|---|
| Female, | 157 | 68 (76) | 89 (77) | 0.03 | 0.9 |
| Age, mean (SD) (years) | 87.3 | 87.1 (6.6) | 87.4 (6.4) | −0.39 | 0.7 |
| Length of stay, median (IQR) (days) | 148 (0–776) | 169 (0–872) | 120 (0–649) | 1.26 | 0.2 |
| No. of all drugs §, median (IQR) | 5 (3–7) | 5 (3–6.5) | 4 (2–7) | 0.61 | 0.3 |
| Polypharmacy §,¶, | 105 | 52 (58) | 53 (46) | 3.07 | 0.08 |
| No. of psychotropic drugs §, median (IQR) | 1 (0–2) | 1 (0–2) | 1 (0–2) | 0.12 | 0.8 |
| Psychotropic drugs §, | 115 | 53 (60) | 62 (54) | 0.65 | 0.4 |
| BZDRAs §, | 68 | 32 (36) | 36 (31) | 0.49 | 0.5 |
| Antipsychotic drugs §, | 59 | 25 (28) | 34 (30) | 0.05 | 0.8 |
| Antiepileptic drugs §, | 38 | 15 (17) | 23 (20) | 0.07 | 0.6 |
| Antidepressant drugs §, | 16 | 4 (4) | 12 (10) | 2.59 | 0.1 |
| Antihypertensive drugs §, | 95 | 43 (48) | 52 (45) | 0.19 | 0.7 |
| Dementia, | 181 | 82 (92) | 99 (86) | 1.89 | 0.2 |
| Charlson Comorbidity Index, median (IQR) | 1 (1–3) | 1 (1–3) | 1 (1–3) | 0.46 | 0.6 |
| Body mass index, median (IQR) | 20.3 (18.0–22.3) | 20.2 (18.1–22.0) | 20.3 (17.8–22.5) | −0.21 | 0.8 |
| Barthel Index, median (IQR) | 65 (45–80) | 70 (50–90) | 50 (40–75) | 4.30 | <0.0001 |
| Barthel Index ≥ 60 (independent, mildly dependent), | 114 | 64 (72) | 50 (43) | 16.8 | <0.0001 |
SD, standard deviation; IQR, interquartile range; BZDRAs, benzodiazepine receptors agonists (benzodiazepines and non-benzodiazepines); § Presence of prescriptions at the beginning of this study. ¶ The number of medications was five or more at the beginning of this study.
Odds ratios of injury occurrence after falls based on logistic regression analysis.
| Risk Factor | Crude OR | 95% CI | Adjusted OR | 95% CI |
|---|---|---|---|---|
| No. of medication ¶ ≥ 5 | 1.64 | 0.94–2.87 |
|
|
| Female | 0.95 | 0.49–1.82 | 0.91 | 0.44–1.87 |
| Age ≥ 85 y | 0.91 | 0.51–1.63 | 0.94 | 0.49–1.77 |
| Dementia | 1.89 | 0.74–4.82 | 2.52 | 0.87–7.30 |
| CCI ≥ 3 | 0.96 | 0.51–1.79 | 0.98 | 0.50–1.96 |
| BMI < 20 | 1.10 | 0.63–1.94 | 1.29 | 0.70–2.37 |
| Barthel Index ≥ 60 | 3.33 | 1.84–6.01 | 3.46 | 1.84–6.54 |
OR, odds ratio; CI, confidence interval; CCI, Charlson Comorbidity Index; BMI, body mass index. ¶ The number of medications was five or more at the beginning of this study.